Karyopharm Therapeutics Inc.

KPTI XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

170M

Short interest (Jul 15)

27.9%

Net Short (Jul 27 ): 0.4%

Borrow Fee

0.87%

↓ 30.7%

Available Shares

900K

↑ 20.0%

Price Chart

Company Overview

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001503802

Asset Type: CS

Market Data

Market Cap: $167,932,407

Employees: 228

Status: Active

Short Interest

Current Borrow Fee 0.87%

Range: 0.87% - 0.87%

Available Shares 900K

Range: 100K - 950K

Recent Changes

Fee Change: ↓ 20.9%

Available Change: ↑ 5.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime